Gefitinib (‘Iressa’), an epidermal growth factor receptor tyrosine kinase inhibitor, mediates the inhibition of lymph node metastasis in oral cancer cells - Shintani, S; Li, C; Mihara, M; Nakashiro, K; Hamakawa, H (Cancer Lett, 2003)